Disease-specific overall survival in endometrioid ovarian

Weekly dose-dense chemotherapy in first-line epithelial ovarian, fallopian tube, or primary peritoneal cancer treatment (ICON8): overall survival results from an open-label, randomised, controlled, phase 3 trial - The Lancet Oncology

Molecular stratification of endometrioid ovarian carcinoma predicts clinical outcome

Real-World Treatment Patterns, Survival, and Costs for Ovarian Cancer in Canada: A Retrospective Cohort Study Using Provincial Administrative Data

NEw developments IN gynecological Oncology - ppt download

Diagnostics, Free Full-Text

Analysis of recurrence and survival rates in grade 3 endometrioid endometrial carcinoma

Diagnostics, Free Full-Text

The prognosis of stage IA synchronous endometrial endometrioid and ovarian carcinomas

Endometrial Cancer - Surgery and staging - Cancer Therapy Advisor

Molecular stratification of endometrioid ovarian carcinoma predicts clinical outcome

Full article: Deep immune profiling of ovarian tumors identifies minimal MHC-I expression after neoadjuvant chemotherapy as negatively associated with T-cell-dependent outcome

Develop a nomogram to predict overall survival of patients with borderline ovarian tumors

Hormone-receptor expression and ovarian cancer survival: an Ovarian Tumor Tissue Analysis consortium study - The Lancet Oncology